| Literature DB >> 33062061 |
Petros Katsogiannos1, Eva Randell2, Magnus Sundbom3, Andreas Rosenblad1, Jan W Eriksson1, Janeth Leksell1,2.
Abstract
BACKGROUND: To examine the effects of gastric bypass surgery on health-related quality of life (HRQoL) in obese patients with type 2 diabetes, and to investigate their experiences of life adjustments using quantitative and qualitative methods.Entities:
Keywords: Quality of life; RYGB; Type 2 diabetes
Year: 2020 PMID: 33062061 PMCID: PMC7552522 DOI: 10.1186/s13098-020-00597-1
Source DB: PubMed Journal: Diabetol Metab Syndr ISSN: 1758-5996 Impact factor: 3.320
Interview guide used during the 2-year follow-up after metabolic surgery
| Can you tell me how you feel today? |
| Can you tell me about how you lived your life today? |
| Can you tell me about how you view the expectations you had before the surgery and how you feel about them now? |
| How has your physical health been affected by the operation? How has your psychological life been affected by the surgery? |
| How has your social situation been affected by the operation? Has your life been changed by the surgery? If so, in what way? |
| Has something gotten better in your life? Has anything gotten worse in your life? |
| What challenges have you faced after the surgery and how have you handled them? |
| Has your view of yourself been affected by the operation? If so, in what way? |
| Has other people's views of you been affected by the operation? If so, in what way? |
| How do you feel about the time before surgery now? How do you feel about the surgery now? |
| How do you feel about the support you received after the surgery? When do you think of your future when it comes to your living habits? |
| Is there anything you want to add? |
Fig. 1Results for RAND-36 domains at baseline and follow-up at 24 weeks and 2 years
Fig. 2Latent theme themes, subthemes
Results from multiple linear regression models of the effect on change in SF-36 domains from baseline to 6 months and 2 years (outcomes) of a one-percentage-point decrease in weight, BMI, and HbA1c from baseline to 6 months and 2 years (predictors)
| Outcome | Predictor | 6 month follow-up | 2 year follow-up | ||
|---|---|---|---|---|---|
| Adjusted β (95% CI)b | Adjusted β (95% CI)b | ||||
| ΔPF | Weight decrease (%) | − 2.24 (− 5.63; 1.16) | 0.171 | − 0.01 (− 1.55; 1.52) | 0.983 |
| ΔRP | Weight decrease (%) | − 4.60 (4.01; − 1.21) | 0.257 | 0.12 (− 4.40; 4.64) | 0.952 |
| ΔBP | Weight decrease (%) | − 4.43 (− 8.54; − 0.32) | 0.40 (− 3.71; 4.51) | 0.829 | |
| ΔGH | Weight decrease (%) | − 3.55 (− 8.38; 1.30) | 0.131 | − 1.60 (− 4.50; 1.30) | 0.239 |
| ΔVT | Weight decrease (%) | − 2.50 (− 6.90; 1.94) | 0.236 | − 1.36 (− 3.10; 0.39) | 0.111 |
| ΔSF | Weight decrease (%) | 0.71 (− 2.49; 3.91) | 0.626 | − 1.99 (− 4.51; 0.52) | 0.105 |
| ΔEF | Weight decrease (%) | − 5.15 (− 8.25; − 2.04) | − 0.40 (− 3.97; 3.16) | 0.801 | |
| ΔMH | Weight decrease (%) | − 0.68 (− 3.20; 1.83) | 0.553 | − 0.13 (− 1.10; 0.84) | 0.770 |
| ΔPF | BMI decrease (%) | − 2.12 (− 5.12; 0.88) | 0.144 | 0.14 (− 1.27; 1.55) | 0.824 |
| ΔRP | BMI decrease (%) | − 6.83 (− 15.00; 1.33) | 0.091 | 0.60 (− 3.62; 4.81) | 0.753 |
| ΔBP | BMI decrease (%) | − 6.34 (− 10.92; − 1.76) | 0.45 (− 3.41; 4.31) | 0.795 | |
| ΔGH | BMI decrease (%) | − 2.53 (− 6.97; 1.92) | 0.230 | − 0.53 (− 4.05; 1.46) | 0.309 |
| ΔVT | BMI decrease (%) | − 3.42 (− 7.50; 0.65) | 0.900 | − 1.20 (0.56; − 1.57) | 0.154 |
| ΔSF | BMI decrease (%) | 0.11 (− 3.25; 3.48) | 0.941 | − 2.14 (− 4.47; 0.20) | 0.067 |
| ΔEF | BMI decrease (%) | − 3.31 (− 6.75; 0.14) | 0.058 | − 0.17 (− 3.47; 3.13) | 0.908 |
| ΔMH | BMI decrease (%) | − 0.73 (− 2.90; 1.44) | 0.467 | − 0.14 (− 1.04; 0.77) | 0.740 |
| ΔPF | HbA1c decrease (%) | − 1.95 (1.81; 1.42) | 0.791 | − 0.17 (− 1.04; 0.70) | 0.666 |
| ΔRP | HbA1c decrease (%) | -1.80 (1.16; 1.8) | 0.34 | −2.99 (-1.70; 2.62) | 0.025 |
| ΔBP | HbA1c decrease (%) | − 0.78 (− 3.42; 1.85) | 0.518 | 0.09 (− 2.83; 3.01) | 0.073 |
| ΔGH | HbA1c decrease (%) | − 0.69 (− 2.98; 1.60) | 0.512 | 0.01 (− 2.22; 2.20) | 0.996 |
| ΔVT | HbA1c decrease (%) | − 1.05 (− 2.56; 0.45) | 0.145 | − 1.05 (− 2.56; 0.45) | 0.145 |
| ΔSF | HbA1c decrease (%) | − 0.94 (− 2.43; 0.55) | 0.190 | − 1.91 (− 3.91; 0.08) | 0.058 |
| ΔEF | HbA1c decrease (%) | 4.98 (− 1.25; 2.24) | 0.988 | 1.61 (− 0.98; 4.20) | 0.189 |
| ΔMH | HbA1c decrease (%) | − 0.57 (− 1.45; 0.31) | 0.177 | 0.245 (− 0.48; 0.97) | 0.460 |
Italic indicates significant p values
aChange from baseline to follow-up in Physical functioning (PF), Role functioning/physical (RP), Pain (BP), General health (GH), Energy/fatigue (VT), Social functioning (27), Role functioning/emotional (EF, and Emotional well-being (MH)
bAdjusted for values of outcome and predictor variables at baseline